Lower Drug Costs for Families Act

HR 4115, the Lower Drug Costs for Families Act, amends Medicare rebate calculations for prescription drugs to potentially lower costs for beneficiaries. It changes the base year for calculating drug price inflation rebates from 2021 back to 2016 and adjusts how "billing units" are counted for drugs sold in commercial markets. This affects Medicare Part B (supplemental coverage) and Part D (prescription drug plans) by modifying how rebates are determined from drug manufacturers. The bill directly impacts Medicare beneficiaries and pharmaceutical companies that sell drugs covered by Medicare. These changes aim to refine rebate calculations but do not create new benefit programs.